Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia

British Journal of Surgery

Volumn 87, Issue 8, 2000, Pages 1087-1093

  Freedman, J ^a   Lagergren, J ^a,b   Bergstrom R ^b,c   Naslund E ^a   Nyren O ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PANCREAS ENZYME;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILE; CANCER RISK; CARDIA CARCINOMA; CHOLECYSTECTOMY; CONTROLLED STUDY; CORRELATION FUNCTION; ESOPHAGUS CARCINOMA; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PEPTIC ULCER; PRIORITY JOURNAL; RISK FACTOR; STOMACH JUICE; SWEDEN;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHOLECYSTECTOMY; ESOPHAGEAL NEOPLASMS; GASTROESOPHAGEAL REFLUX; HUMANS; MULTIVARIATE ANALYSIS; PEPTIC ULCER; REGRESSION ANALYSIS; RISK FACTORS; STOMACH NEOPLASMS; SWEDEN;

EID: 0033944487     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2000.01459.x     Document Type: Article

References (43)

1. Powell J, McConkey CC. The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1992; 1: 265-9.
2. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1992; 265: 1287-9.
3. Hansson LE, Sparen P, Nyren O. Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg 1993; 80: 374-7.
4. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
5. Marshall RE, Anggiansah A, Owen WA, Owen WJ. The temporal relationship between oesophageal bile reflux and pH in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 1989; 10: 385-92.
6. Stein HJ, Kauer WK, Feussner H, Siewert JR. Bile reflux in benign and malignant Barretes esophagus: effect of medical acid suppression and Nissen fundoplication. J Gastrointest Surg 1998; 2: 333-41.
7. Vaezi MF, Lacamera RG, Richter JE. Validation studies of Bilitec 2000: an ambulatory duodenogastric reflux monitoring system. Am J Physiol 1994; 267: G1050-7.
8. Lillemoe KD, Johnson LF, Harmon JW. Role of the components of the gastroduodenal contents in experimental acid esophagitis. Surgery 1982; 92: 276-84.
9. Kivilaakso E, Fromm D, Silen W. Effect of bile salts and related compounds on isolated esophageal mucosa. Surgery 1980; 87: 280-5.
10. Yamashita Y, Homma K, Kako N, Clark GWB, Smyrk TC, Hinder RA et al. Effect of duodenal components of the refluxate on development of esophageal neoplasia in rats. J Gastrointest Surg 1998; 2: 350-5.
11. Miwa K, Hattori T, Miyazaki I. Duodenogastric reflux and foregut carcinogenesis. Cancer 1995; 75 (Suppl 6): 1426-32.
12. Miwa K, Sahara H, Segawa M, Kinami S, Sato T, Miyazaki I et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996; 67: 269-74.
13. Pera M, Trastek VF, Carpenter HA, Fernandez PL, Cardesa A, Mohr U et al. Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. Ann Thorac Surg 1993; 55: 1386-92; Discussion 1392-3.
14. Wilson P, Jamieson JR, Hinder PA, Anselmino M, Perdikis G, Ueda RK et al. Pathologic duodenogastric reflux associated with persistence of symptoms after cholecystectomy. Surgery 1995; 117: 421-8.
15. Abu Farsakh NA, Stietieh M, Abu Farsakh FA. The postcholecystectomy syndrome. A role for duodenogastric reflux. J Clin Gastroenterol 1996; 22: 197-201.
16. Jazrawi S, Walsh TN, Byrne PJ, Hill AD, Li H, Lawlor P et al. Cholecystectomy and oesophageal reflux: a prospective evaluation. Br J Surg 1993; 80: 50-3.
17. Caldwell MT, McDermott M, Jazrawi S, O'Dowd G, Byrne PJ, Walsh TN et al. Helicobacter pylori infection increases following cholecystectomy. Ir J Med Sci 1995; 164: 52-5.
18. Lorusso D, Misciagna G, Mangini V, Messa C, Cavallini A, Caruso ML et al. Duodenogastric reflux of bile acids, gastrin and parietal cells, and gastric acid secretion before and 6 months after cholecystectomy. Am J Surg 1990; 159: 575-8.
19. Rothwell JF, Lawlor P, Byrne PJ, Walsh TN, Hennessy TP. Cholecystectomy-induced gastroesophageal reflux: is it reduced by the laparoscopic approach? Am J Gastroenterol 1997; 92: 1351-4.
20. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58: 588-90.
21. Graham DY, Yamaoka Y. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter 1998; 3: 145-51.
22. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1 - the analysis of case - control studies. IARC Sci Pub 1980; 32: 5-338.
23. Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology 1993; 105: 130-41.
24. Jazrawi S, Walsh TN, Byrne PJ, Hennessy TP. Cholecystectomy and oesophageal pathology: is there a link? Ir J Med Sci 1993; 162: 209-12.
25. Hyvarinen H, Sipponen P, Kekki M. Chronic gastritis in cholecystectomized patients. Scand J Gastroenterol 1987; 22: 649-54.
26. Menke-Pluymers MB, Hop WC, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993; 72: 1155-8.
27. Liron R, Parrilla P, Martinez de Haro LF, Ortiz A, Robles R, Lujan JA et al. Quantification of duodenogastric reflux in Barrett's esophagus. Am J Gastroenterol 1997; 92: 32-6.
28. Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995; 222: 525-31; Discussion 531-3.
29. Marshall RE, Anggiansah A, Owen WJ. Bile in the oesophagus: clinical relevance and ambulatory detection. Br J Surg 1997; 84: 21-8.
30. Vaezi MF, Richter JE. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 1994; 117: 699-704.
31. Fein M, Ireland AP, Ritter MP, Peters JH, Hagen JA, Bremner CG et al. Duodenogastric reflux potentiates the injurious effects of gastroesophageal reflux. J Gastrointest Surg 1997; 1: 27-33.
32. Champion G, Richter JE, Baezi MF, Singh S, Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994; 107: 747-54.
33. Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242-9.
34. Robles-Campos R, Lujan-Mompean JA, Parrilla-Paricio P, Bermejo-Lopez J, Liron-Ruiz R, Torralba-Martinez JA et al. Role of Helicobacter pylori infection and duodenogastric reflux in the pathogenesis of alkaline reflux gastritis after gastric operations. Surg Gynecol Obstet 1993; 176: 594-8.
35. Varanasi RV, Fantry GT, Wilson KT. Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Helicobacter 1998; 3: 188-94.
36. Vicari JJ, Peek RM, Falk GW, Goldblum JR, Easley KA, Schnell J et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115: 50-7.
37. El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, Feddersen RM. Corpus gastritis is protective against reflux oesophagitis. Gut 1999; 45: 181-5.
38. Newton M, Bryan R, Burnham WR, Kamm MA. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut 1997; 40: 9-13.
39. Werdmuller BF, Loffeld RJ. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997; 42: 103-5.
40. Cameron AJ. Aspirin and gastric ulcer. Mayo Clin Proc 1975; 50: 565-70.
41. Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998; 7: 97-102.
42. Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995; 76: 1116-19.
43. Shearman DJ. The treatment of dyspepsia. Aust Fam Physician 1977; 6: 1028-32.